Survivin ( g ) Adult T-cell Leukemia / Lymphoma December
暂无分享,去创建一个
[1] W. Harrington,et al. First Line Antiviral Therapy Significantly Improves Survival of Patients with Acute, Chronic and Smoldering ATL: a Worldwide Meta-Analysis. , 2009 .
[2] T. Waldmann,et al. Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viability. , 2009, Blood.
[3] K. Yamaguchi,et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] T. Waldmann,et al. Receptor-Directed Therapy of T-Cell Leukemias and Lymphomas , 2008, Journal of immunotoxicology.
[5] R. Ueda,et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] H. Aburatani,et al. A genomic analysis of adult T-cell leukemia , 2007, Oncogene.
[7] T. Waldmann,et al. Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence. , 2006, Blood.
[8] S. Kamihira,et al. Survivin an Important Determinant for Prognosis in Adult T-cell Leukemia: A Novel Biomarker in Practical Hemato-oncology , 2002, Leukemia & lymphoma.
[9] S. Katamine,et al. Primary prevention of HTLV-1 in Japan. , 1997, Leukemia.
[10] T. Waldmann,et al. Distribution of human leukocyte antigens in a population of black patients with human T-cell lymphotrophic virus type I-associated adult T-cell leukemia/lymphoma. , 1996, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[11] D. Altieri. Survivin, cancer networks and pathway-directed drug discovery , 2008, Nature Reviews Cancer.